Delivery Order SPE2DB24D1107-SPE2DB25FZFC2

Award Date 4/28/25
Potential Completion Date 4/29/25
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 25 mg tablets, a medication used to treat diabetes. The contract has a ceiling value of $16,828.41 and a period of performance through April 2, 2025. This contract is not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Jardiance 25 mg tablets, a medication used to treat diabetes. The contract has a ceiling value of $3,914.64 and a performance period through May 1, 2025. It is a firm-fixed-price contract, indicating a predetermined price for the delivered items. The contract is not set aside for any specific...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 25 mg tablets, a medication used to treat diabetes. The contract has a ceiling value of $11,621.96 and a period of performance through April 24, 2025. It is a firm fixed-price contract, and there is no set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 25 mg tablets, a medication used to treat diabetes. The contract has a ceiling value of $10,406.72 and a period of performance through April 3, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Jardiance 25 mg tablets, a medication used for the treatment of diabetes. The contract has a ceiling value of $14,913.88 and a completion date of January 13, 2025. It is a firm-fixed-price contract, with no set-aside requirements. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Jardiance 25 mg tablets, a medication used to manage diabetes. The contract has a ceiling value of $20,715.99 and runs through January 18, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 25 mg tablets, a medication used to treat type 2 diabetes. The contract has a ceiling value of $14,582.67 and an ultimate completion date of November 30, 2022. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Jardiance 25 mg tablets, a medication used to treat diabetes. The contract has a ceiling value of $28,692.91 and a period of performance through June 3, 2024. It is a firm-fixed price contract, meaning the price is set and will not change. The contract is not designated as a set-aside, indicating it was awarded...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Jardiance 25 mg tablets, a medication used to treat diabetes. The contract has a ceiling value of $1,944.57 and is a firm fixed-price, non-set-aside contract with a performance period through May 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 25 mg tablets, a medication used to treat diabetes. The contract has a ceiling value of $3,070.83 and a completion date of November 28, 2023. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen...
  • SPE2DB24D1107
    Indefinite Delivery Contract
  • SPE2DB24D1107-SPE2DB25FZFC2
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Jardiance 25 mg tablets, a medication used to treat diabetes. The contract has a ceiling value of $13,562.17 and is a firm fixed-price contract. The period of performance extends through April 29, 2025. This contract is not associated with a set-aside program and was competitively awarded. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs and other government agencies.

Generated 7/28/25, 11:15 AM